(MedPage Today) — Free-market healthcare won’t last long in modern society, says Saurabh Jha, MD
Proliferative Vitreoretinopathy (PVR) Therapeutics Development Pipeline Review, H1 2016 Featuring Novartis, Promedior & RXi Pharmaceuticals – Research and Markets
DUBLIN–(BUSINESS WIRE)–Research and Markets has announced the addition of the “Proliferative Vitreoretinopathy (PVR) – Pipeline Review, H1 2016” report to their offering. This report provides comprehensive information on the therapeutic development f…
Researchers analyze post-Ebola syndrome survivors to improve ongoing treatment
Researchers from the University of Liverpool and the King’s Sierra Leone Partnership are to present new findings into post-Ebola syndrome at a major European conference this week.
Valeant board issues statement on CEO’s cooperation with Senate Committee on Aging
Valeant Pharmaceuticals International’s Board of Directors issued a statement in a press release regarding the Senate Committee on Aging’s subpoena to depose J. Michael Pearson, Valeant’s CEO.”The board has requested Mr. Pearson’s cooperation in connec…
Lung ultrasound may be highly effective, safe for diagnosing pneumonia in children
Lung ultrasound has been shown to be highly effective and safe for diagnosing pneumonia in children and a potential substitute for chest X-ray, according to a study conducted at the Icahn School of Medicine at Mount Sinai. Results are currently publish…
Pioneer of vitreoretinal surgery gives pearls on retinal detachment surgery complications
BASSANO DEL GRAPPA, Italy — Retinal detachment surgery is successful nowadays in more than 90% of cases, but complications that involve the macula may still occur and jeopardize functional outcomes. “The anatomic result is perfect, but the patient complains of vision loss, blurred, distorted or double vision. This is often due to complications of unknown etiology or to well-known complications that are very difficult to treat,” Vito De Molfetta, MD, said here at the Bassano Ophthalmology Meeting.